BioCryst Pharmaceuticals, Inc. (BCRX) NASDAQ
8.34
-0.23(-2.68%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.64B |
| Enterprise Value | 2.02B |
| P/E Ratio | -4.41 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 1.98 |
| Price/Book Ratio | -3.65 |
| Enterprise/Revenue | 2.75 |
| Enterprise/EBITDA | -6.5 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.52 |
| Operating Margin | -0.43 |
Management Effectiveness
| Return On Assets | -0.98 |
| Return On Equity | 1.24 |
Income Statement
| Revenue | 874.84M |
| Revenue/Share | 3.66 |
| Gross Profit | 855.76M |
| EBITDA | 347.65M |
| Net Income | 263.86M |
| Diluted EPS | 1.21 |
Balance Sheet
| Total Cash | 239.25M |
| Total Cash/Share | 0.99 |
| Total Debt | 858.08M |
| Total Debt/Equity | -1.55 |
| Current Ratio | 1.91 |
| Book Value Per Share | -2.29 |
Price History
| 52-Week Change | -22.27 |
| 52-Week High | 11.31 |
| 52-Week Low | 6 |
| Moving Average 50 Days | 9.13 |
| Moving Average 200 Days | 7.92 |
Statistics
| Average Volume | 5.31M |
| Shares Outstanding | 209.89M |
| % Held by Institutions | 117.31 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
